Johnson & Johnson Vision announced today that it received FDA approval for its Acuvue Theravision with Ketotifen. The eye health business arm of Johnson & Johnson (NYSE:JNJ) designed Acuvue Theravision with ketotifen (etafilcon A drug-eluting contact lens with ketotifen) to provide a new wearing experience for contact lens wearers who have allergic eye itch for up to 12 […]
Optical/Ophthalmic
Ocular Therapeutix misses on Q4 projections
Ocular Therapeutix (NSDQ:OCUL) shares ticked up today despite fourth-quarter results that missed the consensus revenue forecast. The Bedford, Massachusetts-based company posted losses of $3.9 million, or 5¢ per share, on sales of $12.3 million for the three months ended Dec. 31, 2021, for a massive bottom-line gain moving from $85.6 million in losses this time […]
Staar Surgical grows sales 28% in Q4 results
Staar Surgical (NSDQ:STAA) posted fourth-quarter results this week that beat the earnings consensus on Wall Street and missed revenue estimates. The Lake Forest, California-based company reported profits of $4.9 million, or 10¢ per share, on sales of $59 million for the three months ended Dec. 31, 2020, for a bottom-line gain of 47.9% on sales growth […]
Glaukos rises on Street-beating Q4
Glaukos (NYSE:GKOS) shares ticked up today on fourth-quarter results that beat the consensus forecast. The San Clemente, California-based eye disease treatment developer posted losses of $21.9 million, or losses per share of 47¢, on sales of $73.2 million for the three months ended Dec. 31, 2021, for a bottom-line slide deeper into the red on […]
What happens when bionic eye implants suddenly go dark?
An update on the Second Sight Medical Products (NASDAQ:EYES) saga comes to us by way of IEEE Spectrum, offering a cautionary tale for the developers of cutting-edge implants and the patients who place their faith in them. The future remains cloudy for the Los Angeles–based developer of the Argus 2s retinal prosthesis system, which is […]
Alcon stock up on Street-beating Q4
Alcon (SIX/NYSE:ALC) stock is up today after the eye care tech company reported fourth-quarter results that surpassed Wall Street expectations. Geneva, Switzerland–based Alcon yesterday evening reported profits of $139 million, or 28¢ per share, off $2.149 billion in sales for the quarter ended Dec. 31, 2021, for a bottom-line gain of 46% and a top-line […]
Minnetronix and INO team up on optical medical device development
Minnetronix Medical and INO Innovation Center today announced a strategic partnership to innovate and accelerate the development of optical medical devices. For their first completed project, INO developed a smart illumination system for an unidentified customer and Minnetronix led the system integration. The companies said in a news release that their partnership can also manage […]
Glaukos announces executive leadership changes
Glaukos this week announced several executive leadership changes that will take place on April 1. Joseph Gilliam is appointed as president and COO. He previously served as the CFO and SVP of corporate development for the San Clemente, California-based ophthalmic medtech and pharma company since 2017. Here are Glaukos’ new executive committee appointments: Chris Calcaterra […]
These medtech companies care a lot about research
They’re making glaucoma-treating stents, tumor-treating fields, coin-sized CGMs and more. Discover the medtech companies that spend the most on research as a percentage of revenue. The list comes from our annual Big 100 report, which examines the world’s 100 largest medical device companies and ranks them by revenue. (Check out our full Big 100 report […]
FDA grants breakthrough designation for WaveGate closed-loop spinal cord stimulation
Wavegate announced today that it received FDA breakthrough device designation for its StimuLux optical reflectometry system. Lake Charles, Louisiana-based Wavegate designed the StimuLux system for the closed-loop adaptive modulation of spinal cord stimulation. Breakthrough designation will expedite the development and regulatory review processes for the platform. According to a news release, StimuLux makes up part […]
Alcon closes Ivantis acquisition
Alcon (NYSE:ALC) announced today that it completed its $475 million acquisition of glaucoma surgery device maker Ivantis. Geneva, Switzerland-based Alcon initially announced the acquisition of Ivantis, which develops the Hydrus Microstent minimally invasive glaucoma surgery (MIGS) device, in November 2021. Get the full story at our sister site, Medical Tubing & Extrusion.
